Turn your post-op recovery into a fashion statement: With designer Olivier Trillon’s concepts, you can choose between an Yves Saint Laurent or Chanel IV bag for your post-op morphine drip.
Hologic Inc. is touting a British study showing that testing pregnant women for a protein produced by the fetus can affect the way doctors treat their patients.
“We see it continuing as a very tough climate to be selling capital equipment in, at least for the next year,” Cumming said. “I expect, from an economic standpoint, a very slow recovery.”
The Bedford-based women’s health products maker reported $41 million in net income on $403 million in sales during the three months ended June 30, a 32 percent drop from the $61 million the company reported on $430 million in sales during the same period last year.
Customer outreach and other marketing efforts may be starting to pay off for Biosphere Medical Inc.
The Rockland, Mass.-based maker of microscopic polymer beads reported $8.1 million in sales during the three months ended June 30, with a 13 percent jump in U.S. sales of the company’s interventional gynecology products pacing much of that gain.
The net loss for the period was $677,000, which compares with a $1.3 million loss on $7.6 million in sales during the June 2008 quarter.
The system is used to treat menorrhagia, or heavy menstrual bleeding, using a 90-second burst of low-frequency radio energy in a roughly 5-minute outpatient procedure.
The Bedford, Mass.-based women’s health products maker said U.S. physicians performed about 312,000 GEA procedures last year, about 205,000 using the NovaSure device, making Hologic’s market share roughly 66 percent.
The Food & Drug Administration gave the nod to Hologic Inc.‘s Adiana sterilization treatment, which uses a minimally invasive natural orifice surgical technique to provide permanent contraception.
The Bedford women’s health products maker said the the federal safety monitor gave pre-market approval for procedure, which involves threading an endoscope through the vagina, cervix and uterus into the fallopian tubes, where radiofrequency energy is applied to small sections of the tube.
Aquamer Medical Corp. is sinking away for good.
The tiny medical device company, unable to find a market for its injectable hydrogel products, is planning to merge with an online-search startup and will become Kwick Search Corp.
The change-over is expected to close by the end of the summer, CEO Marshall Sterman told MassDevice.
Interlace Medical Inc. raised nearly $21 million to begin commercializing its MyoSure minimally invasive system to remove intrauterine fibroids and polyps with an outpatient treatment.
THe Bedford-based women’s health products maker’s stock slipped more than 10 percent in after-hours trading today, to $14 per share, after posting a high of $15.72 during the day.